With the hope of a vaccine to hopefully end the coronavirus pandemic, savvy investors should be on the prowl for stocks poised to rise as life slowly returns to normal.
U.S. drugmaker Pfizer Inc said on Monday its COVID-19 vaccine was 90% effective.
In the wake of that news, brokerage firm Jefferies took a look and listed 67 stocks with “potential upside” looking “beyond the obvious,” Barron’s said.
Barron’s didn't list all 67, but the financial publication did name 10 that haven’t moved as much as others.
- Huntsman (HUN),
- Paccar (PCAR),
- Brinker (EAT),
- Haemonetics (HAE),
- Freeport-McMoRan (FCX),
- Pra Health Sciences (PRAH),
- Blackstone (BX),
- Syneos Health (SYNH),
- Coca-Cola (KO)
- ON Semiconductor (ON)
The stocks cover a range of industries. As Barron’s explained:
- Huntsman is a chemical maker and Freeport is a miner. Both can benefit from higher levels of economic activity coming out of the pandemic-induced recession.
- Heavy-duty truck maker Paccar and ON Semiconductor are linked. ON Semi sells a lot of chips into the car market, and auto sales are improving and set to improve further with an effective vaccine.
- Healthcare stocks such as Haemonetics, Pra and Syneos can benefit from elective procedures and drug research returning to normal.
- Coco-Cola benefits from live sports restarting and Brinker can benefit from restaurants reopening.
- Blackstone is a private-equity player and Jefferies analyst Gerald O’Hara writes: “A vaccine would likely pull forward the ability to achieve regular way private equity exits sooner than the market is expecting.”
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.